Health Canada Clears Apotex’s SEVMIA™ as Canada’s First Generic Wegovy® Equivalent
Apotex Health Corp. has received Health Canada approval for SEVMIA™, a generic semaglutide injection indicated for chronic weight management in adults. The product is Canada’s first approved generic equivalent of Wegovy® and is supplied as a multi-use pre-filled pen. The approval complements a recent clearance for Apo-Semaglutide Injection™ and exp…